State Board of Administration of Florida Retirement System’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,476
Closed -$26.6K 2179
2025
Q1
$26.6K Hold
2,476
﹤0.01% 2144
2024
Q4
$31.7K Hold
2,476
﹤0.01% 2187
2024
Q3
$68.3K Hold
2,476
﹤0.01% 2183
2024
Q2
$71.8K Buy
2,476
+863
+54% +$41.1K ﹤0.01% 2148
2024
Q1
$76.1K Sell
1,613
-863
-35% -$37K ﹤0.01% 2098
2023
Q4
$96.1K Hold
2,476
﹤0.01% 2252
2023
Q3
$72.8K Buy
2,476
+13
+0.5% +$617 ﹤0.01% 2280
2023
Q2
$157K Buy
2,463
+850
+53% +$47K ﹤0.01% 2173
2023
Q1
$76.1K Hold
1,613
﹤0.01% 2188
2022
Q4
$112K Buy
1,613
+185
+13% +$18.4K ﹤0.01% 2191
2022
Q3
$209K Hold
1,428
﹤0.01% 2042
2022
Q2
$186K Buy
+1,428
New +$146K ﹤0.01% 2131

Other funds holding LYEL

State Board of Administration of Florida Retirement System's LYEL Position: Q2 2025 in Review

State Board of Administration of Florida Retirement System sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 2,476 shares — an estimated $26.6K sold.

State Board of Administration of Florida Retirement System first reported a position in LYEL in Q2 2022 and held it in 12 quarters. The position peaked at $209K in Q3 2022. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.

  • State Board of Administration of Florida Retirement System reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 2,476 Lyell Immunopharma shares in Q2 2025, an estimated $26.6K.
  • State Board of Administration of Florida Retirement System first reported a position in Lyell Immunopharma in Q2 2022 and held it in 12 quarters.
  • State Board of Administration of Florida Retirement System's Lyell Immunopharma position peaked at $209K in Q3 2022.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2025, filed 13 Aug 2025.